Hims shares jump on deal to offer Novo’s Wegovy, Ozempic on its platform
Original source: https://www.investing.com/news/stock-market-news/hims-shares-jump-after-report-of-novo-nordisk-partnership-that-may-end-legal-feud-4549188
Read More »Analysis-Hims expansion may not come in time for risky GLP-1 business
Original source: https://www.investing.com/news/stock-market-news/analysishims-expansion-may-not-come-in-time-for-risky-glp1-business-4535064
Read More »
🚨THE MARKET IS RED HOLY MOTHER OF MARY – SELL EVERYTHING INCLUDING YOUR MOTHER – MARKET CRASH 11/10🚨
🚀 Copy My Portfolios Automatically → https://marketplace.joinautopilot.com/landing/1218/542069 (Hands-free investing — every trade I make, mirrored to your account.) 📊 Chart Like a Pro with TradingView → https://www.tradingview.com/u/InTheMoneyAdam/?aff_id=114660&aff_sub=YouTube (My favorite tool…
Read More »Novo Nordisk opens new front with patent suit over Hims’ Wegovy copies
Original source: https://www.investing.com/news/stock-market-news/novo-nordisk-opens-new-front-with-patent-suit-over-hims-wegovy-copies-4495878
Read More »US signals crackdown on compounded weight-loss drugs; Hims shares tumble
Original source: https://www.investing.com/news/stock-market-news/fda-to-restrict-glp1-ingredients-used-in-nonapproved-compounded-drugs-4492113
Read More »
$NVDA $AMD 15% China Chip Deal Sparks Market Moves | Pre-Market Aug 11 🚀
Live stock market coverage and day trading setups for today’s market action. Join us for live afternoon trading as Tesla (TSLA), Palantir (PLTR), Apple (AAPL), and the Nasdaq rebound! Watch…
Read More »Hims to cut 4% of workforce amid ban on weight-loss drug copies
Original source: https://www.investing.com/news/stock-market-news/hims-to-cut-4-of-workforce-amid-ban-on-weightloss-drug-copies-4073795
Read More »